Scientists at the University of Liverpool have discovered how fish have evolved over the last 400 million years to stay motionless at different water depths.

A research team led by Dr Michael Berenbrink, a Comparative Physiologist at the School of Biological Sciences, has revealed how modern fish, such as pike and cod, have developed a way of floating at certain water levels using a gas-filled swimbladder.

The Food and Drug Administration (FDA) today approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone.

Implanted devices intended to optimize the cardiac function of patients with heart failure have provided new insights into which patients might be at higher risk of dying suddenly from their disease, according to researchers at Duke University Medical Center.

Virginia Commonwealth University researchers have identified several genetic changes in the brains of mice caused by ethanol, which may help researchers better understand how and why people become addicted to alcohol.

Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the introduction of the Applied Biosystems Advanced Gene Expression Service Provider Program, a new program for service providers who are interested in accessing Applied Biosystems comprehensive solution for gene expression analysis, including the highly sensitive Expression Array System for whole genome analysis and gold-standard TaqMan® Gene Expression Assays for target validation. The program includes a bundled product option for the entire gene expression workflow application and technical and promotional support that is expected to enhance service providers’ business offerings.